Drug Trial Radar · NCT05543187
A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
Last checked: Nov 20, 2026Latest source record: Jan 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5
Actual
Start
Jan 10, 2023
Primary completion
Sep 4, 2023
Study completion Jul 22, 2025
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Sep 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 month
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of the study is to check if TAK-625 improves symptoms of Progressive Familial Intrahepatic Cholestasis (PFIC), side effect from the study treatment or TAK-625, and how much TAK-625 stays in their blood over time. This will help the study sponsor (Takeda) to work out the best dose to give people in the future. The participants will be treated with TAK-625 for up to the end of study (about 34 months). Participants will visit their study clinic 15 times from the start of study. After 15 times visits, participants will visit their study clinic every 12 weeks up to the end of study.
Conditions
- Progressive Familial Intrahepatic Cholestasis (PFIC)
Interventions
TAK-625Drug
TAK-625 orally, twice daily (BID)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the Average Morning Itch Reported Outcome (ItchRO) (Observer Instrument [Obs]) Severity Score Between Baseline and the Average of Week 15 Through Week 26Time frame: Baseline to Week 15 through Week 26
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Kyushu University Hospital
Fukuoka, Japan
Kyoto University Hospital
Kyoto, Japan
Saitama Prefectural Children's Medical Center
Saitama, Japan
University of Tsukuba Hospital
Tsukuba, Ibaraki, Japan
Yokohamashi Tobu Hospital
Yokohama, Kanagawa, Japan
Tsuyama Chuo Hospital
Tsuyama, Okayama-ken, Japan
Osaka University Hospital
Suita, Osaka, Japan
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.